Major players in the hydroxychloroquine market are investing in increasing production capabilities and pushing for clinical trials to keep up with the massive demand arising from the covid-19 crisis.
ROCKVILLE, MD / ACCESSWIRE / July 27, 2020 / The hydroxychloroquine market is expected to grow at around 4% CAGR, between the years 2020 and 2030). Demand for this antimalarial has shot up following the suggestion of the drug being used as a potential treatment for the coronavirus crisis, by President Trump of the United States.
The United States Center for Disease Control and Prevention, has stated that the drug has displayed in-vitro effects against different types of coronavirus, which will help sustain demand through the end of the pandemic.
"Despite, a number of trials, there has been no definitive evidence of the efficacy of hydroxychloroquine against covid-19. On the other hand, the drug is effective against other diseases, which will help keep demand stable even after the pandemic ends," says the Fact.MR analyst.
Request a sample of the report to gain in-depth market insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4769
Hydroxychloroquine Market- Key Takeaways
- Hydroxychloroquine is largely sold as an anti-malarial drug, owing to massive demand in developing economies with poor sanitation standards, and large mosquito populations.
- Asia Pacific will remain a major market for hydroxychloroquine driven by major ingredient and drug manufacturing operations in China and India.
Hydroxychloroquine Market- Driving Factors
- Proven efficacy of hydroxychloroquine against malaria and rheumatoid arthritis are primary growth factors.
- Investments from the public and private sectors into pharmaceutical research & development activities enable key market developments.
Hydroxychloroquine Market- Major Restraints
- Concerns over toxicology of hydroxychloroquine when administered without adequate supervision is a challenge to market growth.
- Potential side effects of headaches, nausea, appetite loss, mood changes, skin rashes, and hair loss hurt adoption.
COVID-19 Impact on Hydroxychloroquine Market
The covid-19 pandemic has positively influenced the global hydroxychloroquine market, with anecdotal evidence of its efficacy against the virus. Manufacturers have rapidly invested in bolstering production capacities to keep up with the sudden, unprecedented demand. On the other hand, some manufacturers are facing a crunch in terms of critical ingredients, owing to export restrictions, which will be challenge for market players during the crisis.
Explore the global Hydroxychloroquine market with 78 figures, 64 data tables, along with the table of contents of the report. You can also find detailed segmentation on
https://www.factmr.com/report/4769/hydroxychloroquine-market
Competitive Landscape
The hydroxychloroquine manufacturers are currently grappling with the massive demand arising from the covid-19 pandemic. Consequently, industry collaborations and production facility expansions have become key business strategies.
For instance, Accord Healthcare has announced its plans to increase production to 50 million tablets per month at its UK facility. Mylan has also announced the production of hydroxychloroquine sulfate tablets in its West Virginia facility.
Bayer has also announced increased production and donation of hydroxychloroquine doses to the Strategic National Stockpile. Mylan, Abcam plc, Laurus Labs, Advanz Pharma, Ipca Laboratories, Amneal Pharmaceuticals, Dr. Reddy's Lab., and Bayer AG Enterprise are some major hydroxychloroquine market players.
About the Report
This study offers readers a comprehensive market forecast of the hydroxychloroquine market. Global, regional and country-level analysis of the top industry trends impacting the hydroxychloroquine market is covered in this FACT.MR study. The report offers insights on the hydroxychloroquine market on the basis of drug type (anti-malarial, anti-rheumatic, lupus suppressant, anti-covid-19, and others) across five regions (North America, Latin America, Europe, Asia Pacific, and MEA).
Explore FACT.MR's Comprehensive Coverage of Chemical & Materials Landscape
OTC Herbal and Traditional Medicines Market- Get the latest insights on the global OTC herbal and traditional medicines market through FACT.MR's report covering analysis for projection period (2017-2022).
Diuretic Drugs Market- FACT.MR's study on the global diuretic drugs market covers trends, tech innovations, players, and strategies for 2018-2028.
Originator Small Molecule Drug Market- Obtain analysis on the global originator small molecule drug market through FACT.MR's latest report covering competitive analysis, regions, and segment analysis for 2018-2028.
About Fact.MR
Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FACT.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the pharmaceuticals sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services.
Contact:
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: [email protected]
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1537/global-hydroxychloroquine-market
SOURCE: FactMR